TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Dec 4, 4:07 PM ET

Lichtenstein Chen 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Dec 4, 2024

Insider Transaction Report

Form 4
Period: 2024-12-02
Transactions
  • Award

    Restricted Share Units

    2024-12-02+4,8044,804 total
    Ordinary Shares (4,804 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on December 2, 2024 and vest on December 2, 2025.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4